Clinical trial
PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis
NCT00132938 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00132938 |
|---|---|
| Title | PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis |
| Official title | An Open-label, Randomized, Multicenter, Clinical Study to Compare the Effects of Telithromycin, Azithromycin and Cefuroxime Axetil on the Penicillin or Macrolide Resistance of Streptococcus Pneumoniae in Patients With Acute Exacerbation of Chronic Bronchitis |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Bronchitis |
| Intervention type | Drug |
| Interventions | telithromycin |
| Enrollment | 5,660 |
| Start date | Jan 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Aug 22, 2005 |
| Last update posted | Jun 8, 2011 |
| Countries | Belgium, France, Hungary, Morocco, Spain, Tunisia, Turkey (Türkiye), United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: